BD Biosciences Pharmingen Designated One of the Best Workplaces for Commuters(SM) by U.S. EPA and DOT
July 27 2004 - 2:42PM
PR Newswire (US)
BD Biosciences Pharmingen Designated One of the Best Workplaces for
Commuters(SM) by U.S. EPA and DOT SAN JOSE, Calif., July 27
/PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) today
announced that its BD Biosciences Pharmingen unit has been
designated one of the Best Workplaces for Commuters(SM) by the U.S.
Environmental Protection Agency (EPA) and U.S. Department of
Transportation (DOT). Best Workplaces for Commuters(SM), a
voluntary partnership program designed to cut traffic congestion
and traffic-related air pollution, recognizes employers that
provide environmentally friendly commuter benefits to employees.
Offering these commuter benefits identifies BD Biosciences as an
organization committed to reducing pollution, commuting costs,
traffic congestion, and employee stress caused by single-occupant
vehicle commuting. As part of a comprehensive commuter benefits
program, BD Biosciences Pharmingen offers commuting options and
support services such as a web-based program and commuting
information, monthly participation incentives, subsidized transit
fares, a guaranteed emergency ride home program, carpool matching,
and a commuting awards program. "We are proud to make this
commitment to our employees and to the environment," said Kip
Miller, Vice President and General Manager, BD Biosciences
Pharmingen. "The Best Workplaces for Commuters(SM) program is an
example of BD's commitment to a clean environment and supports our
corporate purpose: helping all people live healthy lives."
According to Margo Oge, EPA director of the Office of
Transportation and Air Quality, the effects of incentive programs
like Best Workplaces for Commuters(SM) can be dramatic. "If just
half of all U.S. employees were covered under these commuter
benefits," said Oge, "traffic and air pollution could be cut by the
equivalent of taking 15 million cars off the road every year,
saving American workers about $12 billion in fuel costs. That's
both cleaner air and real savings for families." BD is a medical
technology company that serves healthcare institutions, life
science researchers, clinical laboratories, industry, and the
general public. BD manufactures and sells a broad range of medical
supplies, devices, laboratory equipment, and diagnostic products.
For the fiscal year ended September 30, 2003, BD reported total
revenues of $4.528 billion. Best Workplaces for Commuters(SM)
(http://www.bwc.gov/) is a public-private partnership developed by
the EPA and DOT. EPA and DOT have established a voluntary National
Standard of Excellence for employer-provided commuter benefits. The
program challenges employers across the country to voluntarily meet
the National Standard of Excellence. This press release may contain
certain forward-looking statements (as defined under Federal
securities laws) regarding BD's performance, including future
revenues, products and income, or events or developments that BD
expects to occur or anticipates occurring in the future. All such
statements are based upon current expectations of BD and involve a
number of business risks and uncertainties. Actual results could
vary materially from anticipated results described, implied or
projected in any forward-looking statement. Factors that could
cause actual results to vary materially from any forward-looking
statement include, but are not limited to: competitive factors;
pricing and market share pressures; changes in interest or foreign
currency exchange rates; changes in BD's sales volume and product
mix; BD's ability to achieve its cost savings objectives;
difficulties inherent in product development and delays in product
introductions; changes in regional, national or foreign economic
conditions; increases in energy costs; fluctuations in costs and
availability of raw materials and in BD's ability to maintain
favorable supplier arrangements and relationships; uncertainties of
litigation; and changes in healthcare or other governmental
regulation; issuance of new or revised accounting standards, as
well as other factors discussed in this press release and in BD's
filings with the Securities and Exchange Commission. We do not
intend to update any forward-looking statements. BD, BD logo, and
all other trademarks are the property of Becton, Dickinson and
Company. DATASOURCE: BD (Becton, Dickinson and Company) CONTACT:
Lisa English, PhD, BD Biosciences, Strategic Communications,
+1-408-954-2339, ; Bob Schultze, BD Biosciences Pharmingen,
Facility Operations, +1-858-812-8850, Web site: http://www.bd.com/
http://www.bwc.gov/
Copyright